The US anti-obesity drugs market is on a remarkable trajectory, valued at USD 1.71 billion in 2022 and projected to grow at a staggering CAGR of 26.5% from 2023 to 2030. This growth represents substantial opportunities in a thriving high-volume industry. Are you ready to explore the potential in this expanding market?
For more insights, download our sample report here: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/u-s-anti-obesity-drugs-market-108768